U.S. Awards Contract for COVID-19 Home Test Kit
MONDAY, Feb. 1, 2021 -- The U.S. government has awarded a $231 million contract for production of a recently approved over-the-counter COVID-19 home test kit.
With the product from Australian company Ellume, users can swab themselves at home and check their status in about 20 minutes. It is one of only three consumer self-use tests and the only one available without a doctor's prescription, the Associated Press reported.
Ellume said it would use the contract to build a U.S. manufacturing plant and deliver 8.5 million tests for federal use, but the company did not give a delivery timeframe.
Health experts have long emphasized the need for fast, widespread home testing, but the vast majority of tests still require a nasal swab to be taken by a health worker and sent to a lab for processing, the AP reported.
© 2021 HealthDay. All rights reserved.
Posted: February 2021
Further Support and Information on COVID-19
Read this next
Maternal IgG Antibodies to SARS-CoV-2 Transferred Across Placenta
MONDAY, Feb. 1, 2021 -- Maternal immunoglobulin (Ig)G antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are transferred across the placenta, and cord...
NIH Launches Database to Study COVID-19-Related Neurological Complications
MONDAY, Feb. 1, 2021 – The National Institutes of Health has launched a new database to collect information and biospecimens from people who have experienced neurological...
Physician's Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 25 to 29, 2021. This roundup...